Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators.

OBJECTIVE The purpose of this study was to compare percutaneous transluminal coronary revascularization (PTCR) employing stent implantation to conventional coronary artery bypass graft surgery (CABG) in symptomatic patients with multivessel coronary artery disease. BACKGROUND Previous randomized studies comparing balloon angioplasty versus CABG have demonstrated equivalent safety results. However, CABG was associated with significantly fewer repeat revascularization procedures. METHODS A total of 2,759 patients with coronary artery disease were screened at seven clinical sites, and 450 patients were randomly assigned to undergo either PTCR (225 patients) or CABG (225 patients). Only patients with multivessel disease and indication for revascularization were enrolled. RESULTS Both groups had similar clinical demographics: unstable angina in 92%; 38% were older than 65 years, and 23% had a history of peripheral vascular disease. During the first 30 days, PTCR patients had lower major adverse events (death, myocardial infarction, repeat revascularization procedures and stroke) compared with CABG patients (3.6% vs. 12.3%, p = 0.002). Death occurred in 0.9% of PTCR patients versus 5.7% in CABG patients, p < 0.013, and Q myocardial infarction (MI) occurred in 0.9% PTCR versus 5.7% of CABG patients, p < 0.013. At follow-up (mean 18.5 +/- 6.4 months), survival was 96.9% in PTCR versus 92.5% in CABG, p < 0.017. Freedom from MI was also better in PTCR compared to CABG patients (97.7% vs. 93.4%, p < 0.017). Requirements for new revascularization procedures were higher in PTCR than in CABG patients (16.8% vs. 4.8%, p < 0.002). CONCLUSIONS In this selected high-risk group of patients with multivessel disease, PTCR with stent implantation showed better survival and freedom from MI than did conventional surgery. Repeat revascularization procedures were higher in the PTCR group.

[1]  James T. Willerson,et al.  Appointment of New Associate Editor for Circulation , 1996 .

[2]  Larry S. Dean,et al.  Intracoronary Stenting for Acute and Threatened Closure Complicating Percutaneous Transluminal Coronary Angioplasty , 1992, Circulation.

[3]  W Rutsch,et al.  Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study. , 1996, Circulation.

[4]  R. Kleiger,et al.  Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. , 1999, The New England journal of medicine.

[5]  M. A. Sellers,et al.  Prognostic importance of lower extremity arterial disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI). , 1999, Journal of the American College of Cardiology.

[6]  Hugo A. Katus,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.

[7]  T. Ryan,et al.  Experimental angioplasty: circumferential distribution of laser thermal energy with a laser probe. , 1985, Journal of the American College of Cardiology.

[8]  P. Teirstein,et al.  A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. , 1994, The New England journal of medicine.

[9]  E. Topol,et al.  Is traditionally defined complete revascularization needed for patients with multivessel disease treated by elective coronary angioplasty? Multivessel Angioplasty Prognosis Study (MAPS) Group. , 1993, Journal of the American College of Cardiology.

[10]  C D Naylor,et al.  Assessing the outcomes of coronary artery bypass graft surgery: how many risk factors are enough? Steering Committee of the Cardiac Care Network of Ontario. , 1997, Journal of the American College of Cardiology.

[11]  J. Ornato,et al.  Ability of troponin I to predict cardiac events in patients admitted from the emergency department. , 2000, Journal of the American College of Cardiology.

[12]  D. Antoniucci,et al.  A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) trial. , 1998, Journal of the American College of Cardiology.

[13]  V. Willman,et al.  Aortocoronary bypass with saphenous vein graft. , 1996, JAMA.

[14]  D. Carrié,et al.  Five-year outcome after coronary angioplasty versus bypass surgery in multivessel coronary artery disease: results from the French Monocentric Study. , 1997, Circulation.

[15]  E L Hannan,et al.  Identification of preoperative variables needed for risk adjustment of short-term mortality after coronary artery bypass graft surgery. The Working Group Panel on the Cooperative CABG Database Project. , 1996, Journal of the American College of Cardiology.

[16]  A. Kastrati,et al.  A RANDOMIZED COMPARISON OF ANTIPLATELET THERAPY AFTER THE PLACEMENT OF CORONARY ARTERY STENTS , 1996 .

[17]  M. Debakey,et al.  Aortocoronary Bypass With Saphenous Vein Graft: Seven-Year Follow-Up , 1973 .

[18]  Steve Selvin,et al.  Statistical Analysis of Epidemiologic Data , 1991 .

[19]  I. Palacios,et al.  Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group. , 1993, Journal of the American College of Cardiology.

[20]  T. Investigators.  Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. , 1998, Lancet.

[21]  S. Pocock,et al.  Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery , 1995, The Lancet.

[22]  RITA-2 trial participants.  Coronary angioplasty versus coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial , 1993, The Lancet.

[23]  J. Magovern,et al.  A model that predicts morbidity and mortality after coronary artery bypass graft surgery. , 1996, Journal of the American College of Cardiology.

[24]  J. Alpert,et al.  ACC/AHA guidelines for coronary artery bypass graft surgery: executive summary and recommendations : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1991 guidelines for coronary artery bypass graft surgery). , 1999, Circulation.

[25]  C. Hamm,et al.  A RANDOMIZED STUDY OF CORONARY ANGIOPLASTY COMPARED WITH CORONARY BYPASS SURGERY , 1994 .

[26]  E. Topol.  Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade , 1998, The Lancet.

[27]  Robert L. Frye,et al.  Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. , 1996, The New England journal of medicine.

[28]  E. Rocha.  Identification of variables needed to risk adjust outcomes of coronary interventions: evidence-based guidelines for efficient data collection. , 1998, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[29]  L. Harrell,et al.  Optimal coronary balloon angioplasty with provisional stenting versus primary stent (OCBAS): immediate and long-term follow-up results. , 1998, Journal of the American College of Cardiology.

[30]  I. Palacios,et al.  In-hospital and late results of coronary stents versus conventional balloon angioplasty in acute myocardial infarction (GRAMI trial). Gianturco-Roubin in Acute Myocardial Infarction. , 1998, The American journal of cardiology.

[31]  E. Hannan,et al.  Identification of variables needed to risk adjust outcomes of coronary interventions: evidence-based guidelines for efficient data collection. , 1998, Journal of the American College of Cardiology.

[32]  C. Hamm,et al.  A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI) , 1994, The New England journal of medicine.

[33]  I. Palacios,et al.  Coronary stenting decreases restenosis in lesions with early loss in luminal diameter 24 hours after successful PTCA. , 1995, Circulation.

[34]  J. Ambrose,et al.  Do we require a cure for "stentmania"? , 1996, Journal of the American College of Cardiology.

[35]  S. Yusuf,et al.  Effects of long-term, moderate-intensity oral anticoagulation in addition to aspirin in unstable angina , 2001 .

[36]  J. Moses,et al.  Bailout and corrective use of Gianturco-Roubin flex stents after percutaneous transluminal coronary angioplasty: operator reports and angiographic core laboratory verification from the National Heart, Lung, and Blood Institute/New Approaches to Coronary Intervention Registry. , 1997, Journal of the American College of Cardiology.

[37]  W Rutsch,et al.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.

[38]  G. Bozovich,et al.  CONAREC III . Evolucion de los pacientes sometidos a cirugia coronaria . Estudio multicentrico , 1996 .

[39]  David P Miller,et al.  Abciximab therapy and unplanned coronary stent deployment: favorable effects on stent use, clinical outcomes, and bleeding complications. EPILOG Trial Investigators. , 1998, Circulation.

[40]  Joy,et al.  Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial. , 1993, Lancet.

[41]  W Siegenthaler,et al.  Long-term follow-up after percutaneous transluminal coronary angioplasty. The early Zurich experience. , 1987, The New England journal of medicine.

[42]  P. Walter,et al.  Coronary angioplasty versus coronary artery bypass surgery. , 1996, Israel journal of medical sciences.

[43]  R. Kleiger,et al.  Correction: Outcomes in Patients with Acute Non-Q-Wave Myocardial Infarction Randomly Assigned to an Invasive as Compared with a Conservative Management Strategy. , 1998, The New England journal of medicine.

[44]  E. Braunwald,et al.  Unstable angina. A classification. , 1989, Circulation.

[45]  CABRI Trial Participants,et al.  First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation) , 1995, The Lancet.

[46]  I. Palacios,et al.  Three-year follow-up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI). , 1996, Journal of the American College of Cardiology.

[47]  M. Kutner,et al.  A Randomized Trial Comparing Coronary Angioplasty with Coronary Bypass Surgery , 1994 .